MD Anderson Cancer Center
Targeted Therapy Promising For Cancer Patients - CNL

Patient with metastatic melanoma explains his experience and success on Phase 1 clinical trial. Customizing targeted therapies to each tumor’s molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
Video is loading...
Title: Targeted Therapy Promising For Cancer Patients - CNL
Summary: Patient with metastatic melanoma explains his experience and success on Phase 1 clinical trial. Customizing targeted therapies to each tumor’s molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
Keywords: Metastatic, melanoma, phase 1, clinical trial, targeted therapy, tumor, cancer, Cancer Newsline, Cancerwise
Transcript: